Cutaneous T-cell lymphoma developing during nivolumab treatment for metastatic melanoma
Dermatol Online J
.
2022 Jan 15;28(1).
doi: 10.5070/D328157071.
Authors
Yasutoshi Hida
1
,
Riho Kageji
,
Hirofumi Bekku
,
Shunsuke Watanabe
,
Takuya Seike
,
Michiko Yamashita
Affiliation
1
Division of Dermatology, Tokushima Red Cross Hospital, Komatsushima, Tokushima, Japan.
PMID:
35499424
DOI:
10.5070/D328157071
No abstract available
MeSH terms
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
Melanoma* / drug therapy
Neoplasms, Second Primary*
Nivolumab / adverse effects
Skin Neoplasms* / drug therapy
Substances
Nivolumab